Home > Products > CD16 & CD30
> Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-034)
Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD16 IgG with similar domains from an anti-CD30 antibody via short peptide linkers, or vice versa. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-CD30 Bispecific Antibody (Fv-IgG) (BSDG-034). Click the button below to contact us or submit your feedback about this product.